Partnership expands U.S. entry to Avicenna’s superior imaging AI options by way of Ferrum’s AI Governance Suite.
Medical imaging AI firm Avicenna.AI introduced a strategic partnership with Ferrum, an AI Governance Suite supporting greater than 50 industry-leading algorithms. Underneath the settlement, Ferrum will now commercialize Avicenna.AI’s full portfolio of imaging AI options throughout the US.
Ferrum’s suite offers clinicians entry to superior AI applied sciences designed to reinforce diagnostic accuracy throughout oncology, girls’s and males’s well being, cardiovascular care, neurology, orthopedics, and extra. By including Avicenna’s emergency and high-impact imaging options to its increasing library, Ferrum strengthens its place as probably the most complete AI marketplaces in healthcare.
Avicenna.AI delivers a full suite of deep studying options designed to detect, determine, and quantify life-threatening situations from CT imaging. Its CINA options assist radiologists by accelerating the detection of vital findings, prioritizing pressing circumstances, enhancing workflow effectivity, and bettering affected person outcomes.
Additionally Learn: AiThority Interview That includes: Pranav Nambiar, Senior Vice President of AI/ML and PaaS at DigitalOcean
The portfolio consists of AI options for:
- Intracranial hemorrhage (CINA-ICH)
- Giant vessel occlusion (CINA-LVO)
- Aortic dissection (CINA-AD)
- Pulmonary embolism (CINA-PE and CINA-iPE)
- Vertebral compression fractures (CINA-VCF)
- Cervical backbone fractures (CINA-CSpine)
- ASPECT scoring for stroke severity (CINA-ASPECTS)
Ferrum’s platform permits clinicians to validate AI efficiency on native datasets and combine AI straight into present workflows – with out protected well being info (PHI) ever leaving the well being system’s firewall.
“Radiologists and clinicians are asking for AI that actually strikes the needle for sufferers,” mentioned Pelu Tran, CEO of Ferrum Well being. “Partnering with Avicenna.AI lets us put a few of the most trusted emergency imaging instruments straight into the fingers of the well being programs we serve, increasing entry to life-saving know-how throughout the U.S.”
“Our mission is to make high-performance, clinically confirmed AI accessible to as many clinicians as potential,” mentioned Cyril Di Grandi, co-founder and CEO of Avicenna.AI. “Ferrum’s enterprise-ready platform is the best accomplice to speed up U.S. adoption and guarantee our options are deployed safely, effectively, and at scale.”
Avicenna.AI can be attending RSNA 2025 with a robust presence all through the present, providing demonstrations and displays alongside a number of companions.
Additionally Learn: The Finish Of Serendipity: What Occurs When AI Predicts Each Selection?
[To share your insights with us, please write to psen@itechseries.com ]
